1. Home
  2. PSIX vs NVCR Comparison

PSIX vs NVCR Comparison

Compare PSIX & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$86.27

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.46

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSIX
NVCR
Founded
1985
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PSIX
NVCR
Price
$86.27
$10.46
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$98.76
$26.42
AVG Volume (30 Days)
407.9K
1.4M
Earning Date
03-13-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
122.27
N/A
EPS
5.26
N/A
Revenue
$675,481,000.00
$642,269,000.00
Revenue This Year
$50.35
$10.64
Revenue Next Year
$20.10
$5.37
P/E Ratio
$15.88
N/A
Revenue Growth
54.78
11.17
52 Week Low
$18.10
$9.82
52 Week High
$121.78
$22.95

Technical Indicators

Market Signals
Indicator
PSIX
NVCR
Relative Strength Index (RSI) 62.31 30.78
Support Level $65.96 $9.82
Resistance Level $87.50 $10.64
Average True Range (ATR) 6.44 0.60
MACD 0.94 -0.28
Stochastic Oscillator 93.33 14.49

Price Performance

Historical Comparison
PSIX
NVCR

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: